William B. Walkup & Associates, Inc. Abb Vie Inc. Transaction History
William B. Walkup & Associates, Inc.
- $158 Billion
- Q4 2024
A detailed history of William B. Walkup & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, William B. Walkup & Associates, Inc. holds 25,011 shares of ABBV stock, worth $4.84 Million. This represents 2.81% of its overall portfolio holdings.
Number of Shares
25,011
Previous 25,170
0.63%
Holding current value
$4.84 Million
Previous $4.97 Billion
10.58%
% of portfolio
2.81%
Previous 3.07%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,020Shares Held
1.28BCall Options Held
18.3MPut Options Held
13.4M-
Vanguard Group Inc Valley Forge, PA173MShares$33.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10 Billion0.75% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.49 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...